A Single Dose of Asenapine for the Treatment of Bipolar Patients Affected by Withdrawal Syndrome Induced Psychomotor Agitation: A Pilot, Open-Label Study | Zendy

Maurizio Coppola | Zendy; Raffaella Mondola | Zendy

Open Access

A Single Dose of Asenapine for the Treatment of Bipolar Patients Affected by Withdrawal Syndrome Induced Psychomotor Agitation: A Pilot, Open-Label Study

Author(s) -

Maurizio Coppola,

Raffaella Mondola

Publication year - 2017

Publication title -

journal of reward deficiency syndrome and addiction science

Language(s) - English

Resource type - Journals

ISSN - 2475-1405

DOI - 10.17756/jrdsas.2017-035

Subject(s) - asenapine , psychomotor learning , open label , psychomotor agitation , medicine , bipolar disorder , withdrawal syndrome , anesthesia , psychiatry , pharmacology , mood , cognition , adverse effect

Psychomotor agitation is a medical condition associated with a wide range of psychiatric and non psychiatric diseases including: mood disorders, schizophrenia, personality disorders and drug dependence. In our pilot, open-label study, we evaluated the effect of a single dose of sublingual asenapine in bipolar patients affected by withdrawal syndrome induced psychomotor agitation resistant to the treatment with agonist medicines (methadone, gamma hydroxybutyrate and benzodiazepines).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research